ISSN: 1173-8804

Journal Home

Journal Guideline

BioDrugs Q1 Unclaimed

Switzerland

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

BioDrugs is a journal indexed in SJR in Medicine (miscellaneous) and Biotechnology with an H index of 84. It has a price of 3580 €. It has an SJR impact factor of 2,29 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,29.

BioDrugs focuses its scope in these topics and keywords: treatment, bevacizumab, biosimilar, cancer, randomized, review, avastin, bacterial, biologics, carboplatin, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Biotechnology (Q1) Medicine (miscellaneous) (Q1) Pharmacology (Q1) Pharmacology (medical) (Q1) Pharmacology (medical) (Q1)

Price

3580 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2,29

SJR Impact factor

84

H Index

57

Total Docs (Last Year)

166

Total Docs (3 years)

4439

Total Refs

1115

Total Cites (3 years)

160

Citable Docs (3 years)

6.96

Cites/Doc (2 years)

77.88

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

MMWR. Morbidity and mortality weekly report Q1
Annual Review of Public Health Q1
Annual Review of Clinical Psychology Q1
Journal of Thoracic Oncology Q1
Lancet Digital Health, The Q1

Compare this journals